Until very recently, researchers have been divided on the topic of how testosterone affects heart health. Previously, researchers had claimed that high levels of testosterone were linked to heart disease, while more recent studies have found that low testosterone levels are responsible for an increased risk of heart ailments. There are now hundreds of studies demonstrating testosterone’s profound cardio-protective (heart-protecting) effects. Ultimately, there is now an overwhelming amount of recently published data which shows that maintaining optimal testosterone levels can help prevent cardiovascular disease. “Help” is the key word here. The benefits that come with healthy testosterone levels (not testosterone alone) are what allow the heart to maintain its strength. Therapeutic testosterone, when dosed and maintained to optimal levels, offers no increased risk of CVD (cardiovascular disease) and in recent studies offers clear protection from CVD. The hysteria created by mainstream media about therapeutic testosterone causing an increased number of CVD events in otherwise normal and healthy men is unsupported. One of the biggest myths about Testosterone Optimization Therapy (TOT) is that it increases the risk of cardiovascular events and/or diseases. You may be aware of the many different advertisements (online, print and TV from 2014-2016) about TOT causing heart issues. Those ads claimed that if you’ve used TOT, you may be entitled to a financial recovery. This is because we live in a very lawyer-controlled society and the attorneys filing the lawsuits are opportunistic, not because of TOT causing heart issues. Unsurprisingly, the foundational study that prompted this witch hunt for CVD risk came from a clinical trial called “Testosterone in Older Men” (TOM) which investigated the use of topical testosterone such as transdermal, which is suboptimal in men over 65 with limited mobility. Based on the most recent and relevant research on the matter disputing the Testosterone in Older Men (TOM) and Journal of the American Medical Association (JAMA) studies in question, there is no evidence to support the statement that ‘TOT causes increased risk of heart attacks and strokes’ in any man under the age of 65. Both of those studies were inherently flawed as the patient population groups had previously existing heart and mobility issues as these were not normal, healthy aging men. Put another way, this was a study done on men who could barely walk or move on their own. I mean c’mon. How can any reasonable person assume that this study isn’t completely flawed due to the physical limitations of the subjects involved? In randomized placebo-controlled trials, TOT does not increase the incidence of cardiovascular disease or events such as myocardial infarction, stroke, or angina. In fact, most studies show improved survival in men treated with therapeutic testosterone (versus untreated men). Low levels of testosterone are predictive of an increase in coronary artery disease (CAD), CVD, and cancer. Most of the data available provides clear evidence that supplemental testosterone reduces the risk of cardiovascular events in otherwise healthy and normal men. To read much more about the usage of therapeutic testosterone in men, purchase The TOT Bible.